Hence, EPZ020411, a PRMT6-specific inhibitor, inhibits the methylation of the arginine residue of RCC1 to maximize the positive effects of radiotherapy in a glioblastoma xenograft model99. This evidence concerns the gene RCC1 and glioblastoma.